Biofrontera Stock Analysis

Biofrontera Stock Analysis Notes

About 32.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.29. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biofrontera had not issued any dividends in recent years. The entity had 1:20 split on the 5th of July 2023. Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. Biofrontera operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 69 people. For more info on Biofrontera please contact Erica CPA at 781-245-1325 or go to https://www.biofrontera-us.com.

Biofrontera Investment Alerts

Biofrontera Upcoming and Recent Events

Biofrontera Largest EPS Surprises

View All Earnings Estimates

Biofrontera Stock Institutional Investors

Note, although Biofrontera's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Biofrontera Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.13 M.

Biofrontera Profitablity

The company has Profit Margin (PM) of (0.38) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.65) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.65.

Management Efficiency

Biofrontera has return on total asset (ROA) of (0.4024) % which means that it has lost $0.4024 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4941) %, meaning that it created substantial loss on money invested by shareholders. Biofrontera's management efficiency ratios could be used to measure how well Biofrontera manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.84. The Biofrontera's current Return On Capital Employed is estimated to increase to -2.19. As of now, Biofrontera's Total Current Assets are increasing as compared to previous years. The Biofrontera's current Intangible Assets is estimated to increase to about 2.8 M, while Non Currrent Assets Other are projected to decrease to under 457.9 K.

Technical Drivers

As of the 26th of November, Biofrontera shows the Mean Deviation of 6.11, risk adjusted performance of 0.0062, and Standard Deviation of 8.5. Biofrontera technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Biofrontera Price Movement Analysis

Biofrontera Insider Trading Activities

Biofrontera Outstanding Bonds

Biofrontera Predictive Daily Indicators

Biofrontera Forecast Models

Biofrontera's time-series forecasting models are one of many Biofrontera's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biofrontera's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biofrontera prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biofrontera shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biofrontera. By using and applying Biofrontera Stock analysis, traders can create a robust methodology for identifying Biofrontera entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biofrontera analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biofrontera analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Biofrontera stock analysis indicators help investors evaluate how Biofrontera stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Biofrontera shares will generate the highest return on investment. By understating and applying Biofrontera stock analysis, traders can identify Biofrontera position entry and exit signals to maximize returns.

When running Biofrontera's price analysis, check to measure Biofrontera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera is operating at the current time. Most of Biofrontera's value examination focuses on studying past and present price action to predict the probability of Biofrontera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera's price. Additionally, you may evaluate how the addition of Biofrontera to your portfolios can decrease your overall portfolio volatility.